The digitization of the life sciences sector has introduced complex challenges regarding regulatory compliance. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), mandate that computerized systems used in manufacturing, laboratory testing, and distribution must be validated to ensure they function as intended. Historically, validation efforts were often characterized by a "check-box" mentality, resulting in excessive documentation that added little value to product quality.
To implement GAMP effectively, organizations should: ispe gamp